Virginia Bosó - Concepedia

Author

Virginia Bosó

Hospital Universitari i Politècnic La Fe ORCID

Also Known As

Carmen Ortí Juan, V Bosó, V Bosó Ribelles, V Bosó-Ribelles, V. Boso-Ribelles, V. Bosó, V. Bosó-Ribelles, V. Bosö, V. Bosό, VIRGINIA BOSÓ RIBELLES

Publications

869

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari i Politècnic La Fe Instituto de Investigación Sanitaria La Fe Universitat de València Pontificia Universidad Católica de Chile Hospital Materno-Infantil

About

Virginia Bosó is an author at Hospital Universitari i Politècnic La Fe specializing in medicine, pharmacology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	409
2	Health Sciences	2	2	50
3	Public Health	2	2	48
4	Allergy	1	1	19
5	Biochemistry	1	1	23

Virginia Bosó

Publications

527

Citations

H-Index

Page 1

	Year	Citations
In utero exposure to mycophenolate mofetil: A characteristic phenotype? Antonio Pérez Aytés, Ana da Silva Lédo, Virginia Bosó, American Journal of Medical Genetics Part A Endocrine DisruptorsInfertilityUtero ExposureXenotransplantationMycophenolate Mofetil	2007	164
Mycophenolate mofetil embryopathy: A newly recognized teratogenic syndrome Antonio Pérez Aytés, Purificación Marín Reina, Virginia Bosó, European Journal of Medical Genetics Developmental AnomalyGenetic DisorderPathologyMycophenolate Mofetil EmbryopathyFetal Complication	2016	95
Snps and Taxane Toxicity in Breast Cancer Patients Virginia Bosó, María José Herrero, Ana Santaballa, Pharmacogenomics	2014	51
Impact of<i>ABC</i>single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia Juan Eduardo Megías‐Vericat, Pau Montesinos, María José Herrero, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyAnthracycline UptakeMedicineAcute Myeloid LeukemiaMalignant Blood Disorder	2016	34
Mycophenolate Mofetil During Pregnancy: Some Words of Caution Máximo Vento, Antonio Pérez Aytés, Ana da Silva Lédo, PEDIATRICS ImmunologyTransplantation MedicineGynecologyImmunotherapyHigh-risk Pregnancy	2008	29
Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation Jesús Ruiz Ramos, María José Herrero, Virginia Bosó, International Journal of Molecular Sciences TransplantationMonths Post-transplantationMedicineAbcb1 VariantImmunosuppressive Therapy	2015	29
Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice Mariam Aguas Peris, Virginia Bosó, Belén Navarro, Inflammatory Bowel Diseases	2017	27
Increased Hospital Stay and Allograft Disfunction in Renal Transplant Recipients with Cyp2c19 AA Variant in SNP rs4244285 Virginia Bosó, María José Herrero, Sergio Bea, Drug Metabolism and Disposition	2012	23
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy Juan Eduardo Megías‐Vericat, Pau Montesinos, María José Herrero, The Pharmacogenomics Journal Hematological MalignancyBiochemistryMedicineMixed-phenotype Acute LeukemiaHematology	2017	23
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population Virginia Bosó, María José Herrero, Enrique Busó, Therapeutic Drug Monitoring GeneticsGenetic EpidemiologySpanish White PopulationHuman PolymorphismPharmacotherapy	2013	19

Page 1